Newcastle scientists make 'major breakthrough' in childhood cancer treatment
The research, published in the Journal of Clinical Oncology, shows that alterations in the neuroblastoma’s ALK (anaplastic lymphoma kinase) gene are associated with a significantly poorer prognosis for children with high-risk disease.
Comments